Durham, N.C. — Slate Pharmaceuticals, a startup focused on implantable hormones, has closed on nearly $5 million in funding, The News & Observer in Raleigh reported Wednesday.
Slate, which launched in 2007, also has an office in the United Kingdom.
The firm already markets Testopel, an implantable testosterone pellet.
Slate also is testing a menopausal hormone treatment.
Report: Durham pharmaceutical startup raises some $5M
Copyright 2008 by WRAL.com. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
-
- Inspire Pharmaceuticals launches clinical trial for glaucoma treatment
Oct. 10, 2008 - Veteran life science exec to chair PhaseBio board
Oct. 10, 2008 - FDA decision means delay in $25M payment to PPD
Oct. 10, 2008 - Charlotte Biotechnology Conference to feature N.C. Research Campus
Oct. 10, 2008 - RIP, good times – Venture giant Sequoia warns execs on how to survive coming recession
Oct. 10, 2008
- Inspire Pharmaceuticals launches clinical trial for glaucoma treatment
-
- Who needs ‘crowdsourcing'? Innovation needs experts
Oct. 10, 2008 - S.C. startup MedProcure lands $150K investment
Oct. 10, 2008 - Apple to unveil new products (notebooks?) on October 14
Oct. 9, 2008 - Georgia-based Integrated Broadband Services acquires Canadian firm
Oct. 9, 2008 - Atlanta-based Multicast names CFO who had been CEO of firm acquired by ChannelAdvisor
Oct. 9, 2008
- Who needs ‘crowdsourcing'? Innovation needs experts
More from wrallocaltechwire.com
Market Watch

